Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Donna L. Forrest"'
Autor:
Bo Wan, Lorenzo Lindo, Giovanna Cameron, Yasser Abou Mourad, Shanee Chung, Donna L. Forrest, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, David Sanford, Kevin Song, Ryan J Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer K. White, Claudie Roy, Kevin A. Hay
Publikováno v:
Blood. 140:7555-7557
Autor:
Jessica L. Bazin, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J. Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Shanee Chung
Publikováno v:
Blood. 140:7718-7720
Autor:
Ryan J. Stubbins, Maria Stamenkovic, Claudie Roy, Judith Rodrigo, Shanee Chung, Florian C. Kuchenbauer, Kevin A. Hay, Jennifer White, Yasser Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Donna L. Forrest, Cynthia L. Toze, Heather J. Sutherland, Stephen H. Nantel, Thomas J. Nevill, Aly Karsan, Kevin W. Song, David S. Sanford
Publikováno v:
European Journal of Haematology. 108:437-445
Acute myeloid leukaemia (AML) is a disease of older adults, who are vulnerable to socio-economic factors. We determined AML incidence in older adults and the impact of socio-economic factors on outcomes.We included 3024 AML patients (1996-2016) ident
Autor:
Maria Agustina Perusini, Eshetu G. Atenafu, Donna L. Forrest, Bence-Bruckler Isabelle, Lynn Savoie, Mary-Margaret Keating, Lambert Busque, Robert Delage, Anargyros Xenocostas, Elena Liew, Pierre Laneuville, Kristjan Paulson, Tracy L. Stockley, Jeffrey H. Lipton, Brian Leber, Dennis Dong Hwan Kim
Publikováno v:
Blood. 140:6778-6779
Autor:
Ryan Yen, Sarah Grasedieck, Andrew Wu, Hanyang Lin, Jiechuang Su, Katharina Rothe, Helen Nakamoto, Donna L. Forrest, Connie J. Eaves, Xiaoyan Jiang
Publikováno v:
Leukemia. 36(10)
Despite the effectiveness of tyrosine kinase inhibitors (TKIs) against chronic myeloid leukemia (CML), they are not usually curative as some patients develop drug-resistance or are at risk of disease relapse when treatment is discontinued. Studies ha
Autor:
Igor Novitzky-Basso, Elena Liew, Eshetu G. Atenafu, Lambert Busque, Pierre Laneuville, Kristjan Paulson, Dennis Dong Hwan Kim, Mary-Margaret Keating, Isabelle Bence-Bruckler, Robert Delage, Suzanne Kamel-Reid, Tracy Stockley, Jeffrey H. Lipton, Donna L. Forrest, Brian Leber, Taehyung S Kim, Lynn Savoie, Anargyros Xenocostas
Publikováno v:
British Journal of Haematology. 193:779-791
Although total duration of tyrosine kinase inhibitor (TKI) therapy and of molecular response at 4 log reduction or deeper (MR4) correlates with treatment-free remission (TFR) success after TKI discontinuation, the optimal cut-off values of the durati
Autor:
Katharina Rothe, Artem Babaian, Keith Keith Humphries, Jonathan Zeng, Xiaoyan Jiang, Min Chen, Donna L. Forrest, Hanyang Lin, Oleh Petriv, Inanc Birol, Connie J. Eaves, Jens Ruschmann, Tobias Maetzig, Ryan R. Brinkman, David J.H.F. Knapp, Naoto Nakamichi, Kieran O'Neill, Carl L. Hansen, Ryan Yen, Andrew Wu
Publikováno v:
Blood
Overcoming drug resistance and targeting cancer stem cells remain challenges for curative cancer treatment. To investigate the role of microRNAs (miRNAs) in regulating drug resistance and leukemic stem cell (LSC) fate, we performed global transcripto
Autor:
Raewyn Broady, Michael J. Barnett, Stephen H. Nantel, Cynthia L. Toze, Kevin W. Song, Heather J. Sutherland, Wasithep Limvorapitak, Shruthi Kodad, Maryse M. Power, Alina S. Gerrie, Yasser Abou Mourad, David Sanford, Thomas J. Nevill, Donna E. Hogge, Donna L. Forrest, Jennifer White, Sujaatha Narayanan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:784-790
Background Autologous stem cell transplant (ASCT) is the preferred consolidation strategy to treat eligible patients with multiple myeloma (MM) and related plasma cell dyscrasias. Given the increasing volume of patients and longer wait time, outpatie
Autor:
Dennis Dong Hwan Kim, Lambert Busque, Suzanne Kamel-Reid, Elena Liew, Anargyros Xenocostas, Igor Novitzky Basso, Mary-Margaret Keating, Lynn Savoie, Taehyung Simon Kim, Brian Leber, Tracy Stockley, Robert Delage, Donna L. Forrest, Pierre Laneuville, Kristjan Paulson, Jeffrey H. Lipton, Isabelle Bence-Bruckler, Eshetu G. Atenafu
Publikováno v:
British journal of haematologyReferences. 196(1)
The doubling time (DT) of the BCR-ABL1 quantitative polymerase chain reaction (qPCR) transcript level reflects the re-growing fraction of leukaemic cells after discontinuation of tyrosine kinase inhibitor (TKI). The present study analyzed monthly DT
Autor:
Kevin W. Song, Raewyn Broady, Yasser Abou Mourad, Thomas J. Nevill, Alina S. Gerrie, Maryse M. Power, David Sanford, Heather J. Sutherland, Sujaatha Narayanan, Michael J. Barnett, Stephen H. Nantel, Wasithep Limvorapitak, Donna L. Forrest, Cynthia L. Toze, Donna E. Hogge, Jennifer White
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e481-e491
Optimal post-remission therapy (PRT) for intermediate risk acute myeloid leukemia remains an area of ongoing research. We aimed to retrospectively compare outcomes following autologous stem cell transplantation (autoSCT) with allogeneic SCT (alloSCT)